<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05064098</url>
  </required_header>
  <id_info>
    <org_study_id>21-3576.cc</org_study_id>
    <nct_id>NCT05064098</nct_id>
  </id_info>
  <brief_title>Interpretations and Predictions of Patient Reported Outcomes by Breast Cancer Patients</brief_title>
  <official_title>Interpretations and Predictions of Patient Reported Outcomes by Breast Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will assess how patients' long-term quality of life after different surgical&#xD;
      approaches compares to their predicted quality of life.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will assess how patients' long-term quality of life after different surgical&#xD;
      approaches compares to their predicted quality of life. It will also provide the research&#xD;
      team with improved understanding of how patients interact with and prefer to receive QOL&#xD;
      information. Improved understanding of patient predictions and perceptions of information&#xD;
      display will allow us to incorporate predicted future PROs into the shared decision making&#xD;
      process as well as allow us to provide this important information to patients in a meaningful&#xD;
      way.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">June 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Predicted patient reported outcomes up to 1 year after</measure>
    <time_frame>12 months</time_frame>
    <description>Predicted patient reported outcomes for each domain six-months and 1 year after breast surgery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Actual patient reported outcomes for each domain after surgery</measure>
    <time_frame>6 month</time_frame>
    <description>Actual PRO scores for each domain six-months after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Compare predicted and actual outcomes</measure>
    <time_frame>12 months</time_frame>
    <description>Comparison of predicted versus actual PRO scores in patients undergoing surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patients preferred method of communicating results</measure>
    <time_frame>12 months</time_frame>
    <description>Patients' preferred means of receiving and communicating PRO results.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Pre-Surgical Breast Cancer Patients</arm_group_label>
    <description>Adult female patients newly diagnosed with stage 0-III breast cancer seen as a surgical consultation from 06/01/2019 to present.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Breast Cancer Survivors</arm_group_label>
    <description>Breast Cancer Survivors</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Pre-surgical breast cancer patients and breast cancer survivors&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pre-surgical female breast cancer patients&#xD;
&#xD;
          -  Female breast cancer survivors&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Tevis</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Victoria Huynh</last_name>
    <phone>8327202162</phone>
    <email>victoria.d.huynh@cuanschutz.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Colorado Hopspital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Victoria Huynh</last_name>
      <phone>832-720-2162</phone>
      <email>victoria.d.huynh@cuanschutz.edu</email>
    </contact>
    <investigator>
      <last_name>Sarah Tevis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 29, 2021</study_first_submitted>
  <study_first_submitted_qc>September 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2021</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

